Feature | Coronavirus (COVID-19) | January 19, 2022 | By Avielle Siegel, Paul J. Chang, David M. Paushter, et al.

ITN's new feature, Clinical Case of the Month, features images and clinical case studies from your medical imaging colleagues

A 26-year-old man with history of diabetes and hypertension presented with 7 days of fever, chills, nausea, intractable vomiting, diarrhea and generalized weakness, but no specific upper or lower respiratory symptoms aside from mild shortness of breath.

A 26-year-old man with history of diabetes and hypertension presented with 7 days of fever, chills, nausea, intractable vomiting, diarrhea and generalized weakness, but no specific upper or lower respiratory symptoms aside from mild shortness of breath.


A 26-year-old man with history of diabetes and hypertension presented with 7 days of fever, chills, nausea, intractable vomiting, diarrhea and generalized weakness, but no specific upper or lower respiratory symptoms aside from mild shortness of breath. The patient was diaphoretic and retching on arrival. Physical examination showed diffuse abdominal tenderness, mild tachypnea and tachycardia.

Imaging Findings

A computed tomography (CT) scan of the abdomen and pelvis revealed imaging findings in the lung bases of peripheral nodular airspace and ground-glass opacities. Abdominal imaging findings showed hepatosplenomegaly and severe hepatic steatosis; no abnormalities in the gastrointestinal tract, mesentery or vasculature; and no lymphadenopathy or ascites. 

Diagnosis: Coronavirus Disease (COVID-19)

Subsequent CT chest and SARS-CoV-2 PCR testing confirmed the diagnosis of COVID-19. The patient was admitted to the hospital with a primary diagnosis of diabetic ketoacidosis, the likely cause of his abdominal pain, secondary to SARS-CoV-2 infection. The patient was discharged home 9 days later. 

Further Reading

Information for this case study was provided by the American Roentgen Ray Society (ARRS). Learn more by reading the open-access AJR article “Lung Base Findings of Coronavirus Disease (COVID-19) on Abdominal CT in Patients With Predominant Gastrointestinal Symptoms,” as well as “Unexpected Findings of Coronavirus Disease (COVID-19) at the Lung Bases on Abdominopelvic CT.” 

Call for Entries

Do you have a clinical case you’d like to share with ITN's audience? If so, please send high-resolution images and a brief written case study to [email protected]

Related COVID-19 imaging


Related Content

News | Radiopharmaceuticals and Tracers

June 1, 2026 — Serac Healthcare Ltd. has presented Phase 2 data showing that SPECT-CT imaging with the radiotracer 99mTc ...

Time June 01, 2026
arrow
News | Radiology Business

May 22, 2026 — The American College of Radiology (ACR) supports passage of the Medicare Access to Radiology Care Act (S ...

Time May 26, 2026
arrow
News | Radiology Business

May 22, 2026 — U.S. Sens. Boozman, R-AR, and Luján, D-NM, have introduced the Medicare Access to Radiology Care Act ...

Time May 26, 2026
arrow
Feature | Enterprise Imaging | Kyle Hardner

For radiology departments, the imbalance between surging imaging volume and a shortage of trained radiologists is taking ...

Time May 20, 2026
arrow
News | Radiology Imaging

May 18, 2026 — DICO, a company specializing in the creation of distributed diagnostic infrastructure for radiology, has ...

Time May 19, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

April 27, 2026 — SimonMed, one of the nation’s largest independent outpatient imaging providers, has announced the ...

Time May 04, 2026
arrow
News | Computed Tomography (CT)

April 23, 2026 — Royal Philips has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its ...

Time April 30, 2026
arrow
News | X-Ray

April 29, 2026 — Results from a new study* presented at the American Roentgen Ray Society’s (ARRS) 2026 annual meeting ...

Time April 29, 2026
arrow
News | Radiology Business

April 28, 2026 — The American Society of Radiologic Technologists will award Life Member status to three longstanding ...

Time April 29, 2026
arrow
News | Imaging Software Development

April 28, 2026 — Avatar Medical has been granted FDA 510(k) clearance for Avatar Medical Vision, its software platform ...

Time April 28, 2026
arrow
Subscribe Now